OPERATING INCOME OF $20.9 MILLION; EX-ITEMS, $16.6 MILLION, UP OVER 14% SEQUENTIALLY AND DOWN 9% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF OVER 12%, EXPANDED 120 BASIS POINTS SEQUENTIALLY, WITH ...
Shares of Core Laboratories Inc. CLB gained momentum over the last month, following a staggering rise of 13% in just one month. During the same time period, the company’s shares outperformed the ...
Core Laboratories (CLB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
Hosted on MSN
Core Laboratories projects Q4 2025 revenue of $132M–$136M as international demand drives growth
Gwendolyn Schreffler, Senior Vice President, projected Core's fourth quarter 2025 revenue to range from $132 million to $136 million with operating income of $14 million to $16.1 million and operating ...
Read Core Laboratories Inc. (CLB) Q3 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...
HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of ...
HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback